Galixir
PrivateLast Round
VC Round
Aug 4, 2021
Total Funding Raised
$10M
Company Overview
Galixir is a biotechnology company that leverages artificial intelligence to accelerate preclinical drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Vertical SaaS
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Galixir Comparables
Compare Galixir with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MindRank | 91% | |
| StoneWise | 88% | |
| Genesis Molecular AI | 85% |
Galixir Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 4, 2021 | ||||
| Series A Extension | Dec 29, 2020 | ||||
| Series A | Sep 1, 2020 | ||||
| Pre Seed | Aug 17, 2020 | ||||
| Angel | Nov 1, 2019 |
Galixir Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DCM Ventures | Series A Extension, Series A, VC Round, Pre Seed |
| 5Y Capital | VC Round, Pre Seed, Series A Extension, Series A |
| Source Code Capital | Series A Extension, Series A, VC Round, Pre Seed |
| ACE Redpoint Ventures | VC Round, Series A Extension, Series A |
| BAI Capital | Series A Extension, Series A, VC Round |
| Gaorong Capital | Angel, Series A Extension, Series A, VC Round, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2020
Led by 5Y Capital and ACE Redpoint Ventures.
- Nov 1, 2019
Raised an Angel round with Gaorong Capital participating.
Galixir Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Galixir's valuation, stock price, and market status.
Is Galixir a public or private company?
Galixir is a private company.
What is the current stock price of Galixir?
Galixir is a private company with no public stock price. No recent secondary market data is available.
How much is Galixir worth (valuation)?
Valuation information for Galixir is not publicly available.
Can I buy Galixir stock?
Galixir shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Galixir's last funding round?
Galixir's most recent funding round was VC Round on August 4, 2021.
Who are the main investors in Galixir?
Key investors in Galixir include DCM Ventures, 5Y Capital, Source Code Capital, ACE Redpoint Ventures.
Will Galixir IPO soon?
No public IPO plans have been announced for Galixir.
How can I track Galixir secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Galixir's secondary market activity and sign up for updates.